In vitro/in vivo biocompatibility and mechanical properties of bioactive glass nanofiber and poly(ε-caprolactone) composite materials

Ji Hoon Jo, Eun Jung Lee, Du Sik Shin, Hyoun Ee Kim, Hae Won Kim, Young-Hag Koh, Jun Hyeog Jang

Research output: Contribution to journalArticle

110 Citations (Scopus)

Abstract

In this study, a poly(ε-caprolactone) (PCL)/bioactive glass (BG) nanocomposite was fabricated using BG nanofibers (BGNFs) and compared with an established composite fabricated using microscale BG particles. The BGNFs were generated using sol-gel precursors via the electrospinning process, chopped into short fibers and then incorporated into the PCL organic matrix by dissolving them in a tetrahydrofuran solvent. The biological and mechanical properties of the PCL/BGNF composites were evaluated and compared with those of PCL/BG powder (BGP). Because the PCL/BG composite containing 20 wt % BG showed the highest level of alkaline phosphatase (ALP) activity, all evaluations were performed at this concentration except for that of the ALP activity itself. In vitro cell tests using the MC3T3 cell line demonstrated the enhanced biocompatibility of the PCL/BGNF composite compared with the PCL/BGP composite. Furthermore, the PCL/BGNF composite showed a significantly higher level of bioactivity compared with the PCL/BGP composite. In addition, the results of the in vivo animal experiments using Sprague-Dawley albino rats revealed the good bone regeneration capability of the PCL/BGNF composite when implanted in a calvarial bone defect. In the result of the tensile test, the stiffness of the PCL/BG composite was further increased when the BGNFs were incorporated. These results indicate that the PCL/BGNF composite has greater bioactivity and mechanical stability when compared with the PCL/BG composite and great potential as a bone regenerative material.

Original languageEnglish
Pages (from-to)213-220
Number of pages8
JournalJournal of Biomedical Materials Research - Part B Applied Biomaterials
Volume91
Issue number1
DOIs
Publication statusPublished - 2009 Oct 1

Fingerprint

Nanofibers
Bioactive glass
Biocompatibility
Glass
Mechanical properties
Composite materials
Powders
Bone
Alkaline Phosphatase
Phosphatases
Bioactivity
Nanocomposites
Bone and Bones
Bone Regeneration
polycaprolactone
In Vitro Techniques
Polymethyl Methacrylate
Sprague Dawley Rats
Mechanical stability
Electrospinning

Keywords

  • Bioactive glass
  • Bone regeneration
  • Composite
  • Nanofiber
  • Polycaprolactone

ASJC Scopus subject areas

  • Biomedical Engineering
  • Biomaterials

Cite this

In vitro/in vivo biocompatibility and mechanical properties of bioactive glass nanofiber and poly(ε-caprolactone) composite materials. / Jo, Ji Hoon; Lee, Eun Jung; Shin, Du Sik; Kim, Hyoun Ee; Kim, Hae Won; Koh, Young-Hag; Jang, Jun Hyeog.

In: Journal of Biomedical Materials Research - Part B Applied Biomaterials, Vol. 91, No. 1, 01.10.2009, p. 213-220.

Research output: Contribution to journalArticle

@article{c929da17ec6948518a9074aa7e9ab3c1,
title = "In vitro/in vivo biocompatibility and mechanical properties of bioactive glass nanofiber and poly(ε-caprolactone) composite materials",
abstract = "In this study, a poly(ε-caprolactone) (PCL)/bioactive glass (BG) nanocomposite was fabricated using BG nanofibers (BGNFs) and compared with an established composite fabricated using microscale BG particles. The BGNFs were generated using sol-gel precursors via the electrospinning process, chopped into short fibers and then incorporated into the PCL organic matrix by dissolving them in a tetrahydrofuran solvent. The biological and mechanical properties of the PCL/BGNF composites were evaluated and compared with those of PCL/BG powder (BGP). Because the PCL/BG composite containing 20 wt {\%} BG showed the highest level of alkaline phosphatase (ALP) activity, all evaluations were performed at this concentration except for that of the ALP activity itself. In vitro cell tests using the MC3T3 cell line demonstrated the enhanced biocompatibility of the PCL/BGNF composite compared with the PCL/BGP composite. Furthermore, the PCL/BGNF composite showed a significantly higher level of bioactivity compared with the PCL/BGP composite. In addition, the results of the in vivo animal experiments using Sprague-Dawley albino rats revealed the good bone regeneration capability of the PCL/BGNF composite when implanted in a calvarial bone defect. In the result of the tensile test, the stiffness of the PCL/BG composite was further increased when the BGNFs were incorporated. These results indicate that the PCL/BGNF composite has greater bioactivity and mechanical stability when compared with the PCL/BG composite and great potential as a bone regenerative material.",
keywords = "Bioactive glass, Bone regeneration, Composite, Nanofiber, Polycaprolactone",
author = "Jo, {Ji Hoon} and Lee, {Eun Jung} and Shin, {Du Sik} and Kim, {Hyoun Ee} and Kim, {Hae Won} and Young-Hag Koh and Jang, {Jun Hyeog}",
year = "2009",
month = "10",
day = "1",
doi = "10.1002/jbm.b.31392",
language = "English",
volume = "91",
pages = "213--220",
journal = "Journal of Biomedical Materials Research - Part B Applied Biomaterials",
issn = "1552-4973",
publisher = "John Wiley and Sons Inc.",
number = "1",

}

TY - JOUR

T1 - In vitro/in vivo biocompatibility and mechanical properties of bioactive glass nanofiber and poly(ε-caprolactone) composite materials

AU - Jo, Ji Hoon

AU - Lee, Eun Jung

AU - Shin, Du Sik

AU - Kim, Hyoun Ee

AU - Kim, Hae Won

AU - Koh, Young-Hag

AU - Jang, Jun Hyeog

PY - 2009/10/1

Y1 - 2009/10/1

N2 - In this study, a poly(ε-caprolactone) (PCL)/bioactive glass (BG) nanocomposite was fabricated using BG nanofibers (BGNFs) and compared with an established composite fabricated using microscale BG particles. The BGNFs were generated using sol-gel precursors via the electrospinning process, chopped into short fibers and then incorporated into the PCL organic matrix by dissolving them in a tetrahydrofuran solvent. The biological and mechanical properties of the PCL/BGNF composites were evaluated and compared with those of PCL/BG powder (BGP). Because the PCL/BG composite containing 20 wt % BG showed the highest level of alkaline phosphatase (ALP) activity, all evaluations were performed at this concentration except for that of the ALP activity itself. In vitro cell tests using the MC3T3 cell line demonstrated the enhanced biocompatibility of the PCL/BGNF composite compared with the PCL/BGP composite. Furthermore, the PCL/BGNF composite showed a significantly higher level of bioactivity compared with the PCL/BGP composite. In addition, the results of the in vivo animal experiments using Sprague-Dawley albino rats revealed the good bone regeneration capability of the PCL/BGNF composite when implanted in a calvarial bone defect. In the result of the tensile test, the stiffness of the PCL/BG composite was further increased when the BGNFs were incorporated. These results indicate that the PCL/BGNF composite has greater bioactivity and mechanical stability when compared with the PCL/BG composite and great potential as a bone regenerative material.

AB - In this study, a poly(ε-caprolactone) (PCL)/bioactive glass (BG) nanocomposite was fabricated using BG nanofibers (BGNFs) and compared with an established composite fabricated using microscale BG particles. The BGNFs were generated using sol-gel precursors via the electrospinning process, chopped into short fibers and then incorporated into the PCL organic matrix by dissolving them in a tetrahydrofuran solvent. The biological and mechanical properties of the PCL/BGNF composites were evaluated and compared with those of PCL/BG powder (BGP). Because the PCL/BG composite containing 20 wt % BG showed the highest level of alkaline phosphatase (ALP) activity, all evaluations were performed at this concentration except for that of the ALP activity itself. In vitro cell tests using the MC3T3 cell line demonstrated the enhanced biocompatibility of the PCL/BGNF composite compared with the PCL/BGP composite. Furthermore, the PCL/BGNF composite showed a significantly higher level of bioactivity compared with the PCL/BGP composite. In addition, the results of the in vivo animal experiments using Sprague-Dawley albino rats revealed the good bone regeneration capability of the PCL/BGNF composite when implanted in a calvarial bone defect. In the result of the tensile test, the stiffness of the PCL/BG composite was further increased when the BGNFs were incorporated. These results indicate that the PCL/BGNF composite has greater bioactivity and mechanical stability when compared with the PCL/BG composite and great potential as a bone regenerative material.

KW - Bioactive glass

KW - Bone regeneration

KW - Composite

KW - Nanofiber

KW - Polycaprolactone

UR - http://www.scopus.com/inward/record.url?scp=70049110810&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70049110810&partnerID=8YFLogxK

U2 - 10.1002/jbm.b.31392

DO - 10.1002/jbm.b.31392

M3 - Article

C2 - 19422050

AN - SCOPUS:70049110810

VL - 91

SP - 213

EP - 220

JO - Journal of Biomedical Materials Research - Part B Applied Biomaterials

JF - Journal of Biomedical Materials Research - Part B Applied Biomaterials

SN - 1552-4973

IS - 1

ER -